We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LDO:MILLeonardo SpA Analysis

Data as of 2026-08-28 - not real-time

€53.73

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Leonardo S.p.a. trades at €53.73, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 5.9% over the past 30 days. Momentum indicators put RSI at 40.7 (neutral) with MACD reading bearish. Recent trading has carved out support near €53.61 and resistance around €60.78.
Multiples put this in fair territory: 27.6 times earnings against the sector's 29.6. Sell-side targets cluster 29.0% above the current quote. Revenue is growing at 16.7% on a 5.5% profit margin. The 1.14% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 24.6%, a beta of 0.39 and a maximum drawdown of 28.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.

Top Market Events

Leonardo S.p.A. shares on Borsa Italiana traded slightly weaker in a subdued start to June, as the FLatest Leonardo S.p.A. LDO:MIL share price with interactive charts, historical prices, comparative analysis, forecasts,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 54.06
  • MACD momentum is negative
  • 30-day price change of +5.9%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 27.6 versus sector average of 29.6
  • Trading below the 200-day average of 54.06
  • Analyst targets imply +29.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 27.6 versus sector average of 29.6
  • Analyst targets imply +29.0% versus the current price
  • Revenue growth of +16.7%

Key Metrics & Analysis

Financial Health

Revenue Growth16.70%
Profit Margin5.47%
P/E Ratio27.6
ROE11.89%
ROA3.32%
Debt/Equity41.53
P/B Ratio3.2
Op. Cash Flow€2.2B
Free Cash Flow€1.1B
Industry P/E29.6

Technical Analysis

TrendNeutral
RSI40.7
Support€53.61
Resistance€60.78
MA 20€57.23
MA 50€53.53
MA 200€54.06
MACDBearish
VolumeDecreasing
Fear & Greed Index95.61

Valuation

Fair Value€42.34
Target Price€69.31
Upside/Downside28.99%
GradeFair
TypeBlend
Dividend Yield1.14%

Risk Assessment

Beta0.39
Volatility24.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.